Fora Capital, LLC Tcr2 Therapeutics Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.44 - $18.35 $22,011 - $47,856	-2,608 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.41 - $24.71 $30,768 - $46,331	1,875 Added 255.8%	2,608 $43 Million
Q1 2021 May 17, 2021	SELL	$20.38 - $34.07 $131,023 - $219,036	-6,429 Reduced 89.77%	733 $16 Million
Q4 2020 Feb 12, 2021	BUY	$19.0 - $32.63 $136,078 - $233,696	7,162 New	7,162 $221,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.